← Leaderboards
Steven A. Gunzler
Case Western Reserve University
$784,552
Attributed
$2,890,511
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $743.1K · FY2020–23$1M$750K$500K$250K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$2,890,511 · 1
By mechanism
U01$2,890,511 · 1
Top collaborators
- Shu G Chen4 shared
- Qingzhong Kong3 shared
- Zerui Wang3 shared
- Wen-Quan Zou1 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Witold K Surewicz$20,523,800
- Pierluigi Gambetti$33,097,698
- Shu G Chen$11,007,717
- Qingzhong Kong$9,304,366
- Neena Singh$9,545,188
Others in their field
Other Emerging Leaders on “Diagnosis”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$141,100,782
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
Research focus
DiagnosisDiagnostic TestsDepositionDetectionAlzheimer&AposAutopsyAlpha SynucleinAffectAmyloid Beta-ProteinBiopsyAreaBloodBody FluidsBrainBrain TissueCadaverBiological MarkersCerebrospinal FluidCohortCohort StudiesCorticobasal DegenerationCreutzfeldt-Jakob SyndromeBiopsy SpecimenDisorder Control
Grant awards (4)
Assessing skin biomarkers for preclinical diagnosis of PD and non-PD Parkinsonism$729,340
U01 · FY2023 · NS
Assessing skin biomarkers for preclinical diagnosis of PD and non-PD Parkinsonism$709,041
U01 · FY2022 · NS
Assessing skin biomarkers for preclinical diagnosis of PD and non-PD Parkinsonism$709,041
U01 · FY2021 · NS
Assessing skin biomarkers for preclinical diagnosis of PD and non-PD Parkinsonism$743,089
U01 · FY2020 · NS